The immune system must be tightly regulated to prevent unwanted tissue damage caused by exaggerated immune and inflammatory reactions. Inhibitory and activating immune receptors play a crucial role in this function via phosphotyrosine‐dependent signaling pathways. A significant body of evidence has accumulated suggesting that the siglec family of sialic acid binding Ig‐like lectins makes an important contribution to this immunoregulation. The CD33‐related siglecs are a distinct subset of inhibitory and activating receptors, expressed primarily on leukocytes in a cell type‐specific manner. Here, we critically assess the in vitro and in vivo evidence on the functional role for CD33‐related siglecs in modulation of inflammatory and immune responses.
| Autoren: |
|
Paul R. Crocker, Sarah J. McMillan, Hannah E. Richards |
| Journal: |
|
Annals of the New York Academy of Sciences
|
| Band: |
|
1253 |
| Ausgabe: |
|
1 |
| Jahrgang: |
|
2012 |
| Seiten: |
|
102 |
| DOI: |
|
10.1111/j.1749-6632.2011.06449.x |
| Erscheinungsdatum: |
|
21.02.2012 |